Page last updated: 2024-09-03

4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole and histidine

4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole has been researched along with histidine in 1 studies

Compound Research Comparison

Studies
(4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole)
Trials
(4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole)
Recent Studies (post-2010)
(4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole)
Studies
(histidine)
Trials
(histidine)
Recent Studies (post-2010) (histidine)
500322,0461144,371

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gether, U; Kobilka, BK; Lin, S1

Other Studies

1 other study(ies) available for 4-(n-(iodoacetoxy)ethyl-n-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole and histidine

ArticleYear
Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.
    The Journal of biological chemistry, 1995, Nov-24, Volume: 270, Issue:47

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cell Line; Cysteine; Dihydroalprenolol; Fluorescent Dyes; Histidine; Humans; Isoproterenol; Kinetics; Ligands; Models, Structural; Oxadiazoles; Protein Conformation; Receptors, Adrenergic, beta-2; Recombinant Proteins; Sensitivity and Specificity; Sequence Tagged Sites; Spectrometry, Fluorescence; Spodoptera; Time Factors; Transfection

1995